Effectiveness of Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration with Serous Pigment Epithelial Detachment.

CONCLUSIONS Intravitreal injection of ranibizumab for the treatment of neovascular age-related macular degeneration with serous pigment epithelial detachment safely and effectively improved the patients' visual acuities and decreased their PED heights volumes. PMID: 26972376 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26972376?dopt=Abstract

Source: Medical Science Monitor - March 15, 2016 Category: Research Tags: Med Sci Monit Source Type: research